NGVT
Get informed when a big investor buys or sells
+ FollowOvervalued by 80.3% based on the discounted cash flow analysis.
| Market cap | $2.42 Billion |
|---|---|
| Enterprise Value | $3.52 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.61 |
| Beta | 1.18 |
| Outstanding Shares | 35,000,000 |
| P/E Ratio | 45.63 |
|---|---|
| PEG | -36.77 |
| Price to Sales | 2.24 |
| Price to Book Ratio | 73.99 |
| Enterprise Value to Revenue | 3.03 |
| Enterprise Value to EBIT | 45.99 |
| Enterprise Value to Net Income | 65 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 25.59 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 18.71% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 101.11%▼ 0.67% |
|---|---|
| Total Invested | $2.66B▲ 3.92% |
| Investors Holding | 309▲ 2.00% |
No data
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, an...